COMMUNIQUÉS West-GlobeNewswire

Emerald Health Therapeutics étend la distribution de son huile SYNC 25 CBD à deux autres provinces canadiennes
10/07/2019
Suite au lancement réussi du produit en Colombie-Britannique, l’huile de haute puissance SYNC 25 CBD d’Emerald est maintenant disponible en Alberta et au Saskatchewan VANCOUVER, Colombie-Britannique, 10 juill. 2019 ( [...]
Generex Biotechnology Provides Fiscal Year Overview
10/07/2019
GNBT Reorganization & Transformation Acquisitions: Olaregen Therapeutix, Regentys, Veneto Assets, Pantheon Medical, MediSource Partners Completed 100% Acquisition of HDS (now NuGenerex Diagnostics) and Retired [...]
Nemaura Medical Inc. Submits De Novo 510(k) Application for SugarBEAT® to the U.S. Food and Drug Administration
10/07/2019
Loughborough, England , July 10, 2019 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on the development of SugarBEAT® as a non-invasive, affordable and flexible Continuous [...]
Arcturus Therapeutics to Participate in Two Panels at the ROTH RNA Revolution Conference
10/07/2019
SAN DIEGO, Calif., July 10, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics (NASDAQ: ARCT) (the “Company”), a leading messenger RNA medicines company focused on the discovery, development and commercialization of [...]
Philips and TeleTracking join together as founding sponsors of ‘Command Center Summit: Connected Care Delivery’
10/07/2019
July 10, 2019 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its founding sponsorship of BRI Network’s inaugural Command Center Summit: Connected [...]
Le Dr Peter Libby, cardiologue réputé et pionnier de la recherche sur l'inflammation et les maladies cardiovasculaires, rejoint le conseil d'administration de XBiotech
10/07/2019
AUSTIN, Texas, 10 juill. 2019 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ : XBIT) a annoncé aujourd’hui la nomination du Dr Peter Libby au conseil d’administration de la société. Le Dr Libby a joué un rôle de pionnier [...]
AZTherapies Strengthens Management Team, Adding Industry Veteran Jay Mohr as Chief Operating and Business Officer, Head of Commercial Development
10/07/2019
BOSTON, July 10, 2019 (GLOBE NEWSWIRE) -- AZTherapies, Inc. , a biopharmaceutical company developing therapeutics to extend brain health, today announced the hiring of Jay Mohr as Chief Operating Officer, Chief Business [...]
Myovant Sciences and Evidation Health Announce Partnership and Launch Digital Insights Study on Menstruation
10/07/2019
Digital insights study to include over 20,000 people and evaluate women’s menstrual experiences, including symptoms such as heavy menstrual bleeding and menstrual pain PERIOD. Inc., a Myovant partner and nonprofit [...]
Obalon Strengthens Balance Sheet By Raising Additional Capital And Reducing Debt
10/07/2019
Recent equity capital raising activities position the company to pursue commercial strategy intended to more efficiently leverage the Obalon Balloon System SAN DIEGO, July 10, 2019 (GLOBE NEWSWIRE) -- Obalon [...]
Daniel Blum, CEO at BioHemp International (OTC: BKIT), discusses new position, CBD opportunities, and long-term company goals with Cannabis Hemp Wire
10/07/2019
NEW YORK, July 10, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – Cannabis Hemp Wire’s David Hempstein interviewed new BioHemp International (OTC: BKIT) CEO, Daniel Blum earlier this week to discuss new role, opportunities [...]
BeyondSpring Provides Operational Update and First Quarter 2019 Financial Results
10/07/2019
- New and Compelling Plinabulin Data Presented at Key Scientific Conferences - - To Submit New Drug Applications (NDAs) in China for Both Non-Small Cell Lung Cancer (NSCLC) and Chemotherapy-Induced Neutropenia (CIN) in [...]
Equillium Announces Initiation of the EQUIP Phase 1b Clinical Trial of Itolizumab for Patients with Uncontrolled Asthma
10/07/2019
LA JOLLA, Calif., July 10, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory [...]
Passage Bio Announces New Dedicated Gene Therapy Manufacturing Suite
10/07/2019
Dedicated cGMP suite to be built under strategic partnership agreement with Paragon Gene Therapy to support future clinical and commercial production for Passage Bio’s AAV-delivered gene therapies PHILADELPHIA, July 10 [...]
Multiple Abstracts Highlighting Non-Invasive Vagus Nerve Stimulation (nVNS) to be Presented at the American Headache Society’s 61st Annual Scientific Meeting
10/07/2019
BASKING RIDGE, N.J., July 10, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a global commercial-stage bioelectronic medicine company, today announced data presentations focused on non-invasive vagus nerve [...]
ORYZON to Present Data From ETHERAL Phase IIa Trial at the 2019 Alzheimer's Association International Conference in Los Angeles
10/07/2019
Safety data from the first 90 patients will be presented Parametric evolution of the first (blinded) 33 patients that have been treated for 6 months will also be discussed MADRID, Spain and CAMBRIDGE, Mass., July 10, [...]
IntelGenx to Present at 12th Edition of Clinical Trials on Alzheimer’s Disease
10/07/2019
SAINT LAURENT, Quebec, July 10, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will present a Montelukast poster at the 12 th [...]
XBiotech Adds Dr. Peter Libby, Renowned Cardiologist and Research Pioneer in Inflammation and Cardiovascular Disease, to its Corporate Board
10/07/2019
AUSTIN, Texas, July 10, 2019 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) announced today that Peter Libby, M.D., has been appointed to the Company’s Corporate Board of Directors. Dr. Libby has played a pioneering [...]
GBT and Advocates Launch Disease Awareness Campaign Focused on Breaking Down Stigmas Associated with Sickle Cell Disease
10/07/2019
Company Also Launches Disease Awareness Campaign to Raise Awareness Among Physicians About the Silent Damage Caused by Sickle Cell Disease SOUTH SAN FRANCISCO, Calif., July 10, 2019 (GLOBE NEWSWIRE) -- Global Blood [...]
Axiom Real-Time Metrics Exhibiting at Outsourcing in Clinical Trials Medical Device Conference in Irvine, CA
10/07/2019
TORONTO, July 10, 2019 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services is exhibiting July 10-11, 2019 at OCT Medical Device conference in Irvine, CA. [...]

Pages